The Ecstasy and Related Drug Reporting System (EDRS) is a national drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets, and form part of Drug Trends

Microdosing refers to the practice of routinely ingesting a small quantity of psychedelics, between 5-10% of a standard dose, to obtain the positive effects of the drug, and minimise adverse effects.

Key findings: 

  • One-fifth (21%) of participants reported microdosing in the previous six months
  • The most commonly used substances were hallucinogenic mushrooms and LSD
  • Most participants (56%) reported experiencing no challenges from their microdosing
  • The most commonly reported benefits experienced were enhanced mood/reduced depression, enhanced energy/alertness, and enhanced creativity/curiosity



Natalie Thomas, Mitchell Northcote, Jennifer Juckel, Catherine Daly, Joemer Maravilla, Yalei Wilson, Raimondo Bruno & Caroline Salom
Date Commenced
25 May 2022
Resource Type
Drug Trends Bulletins